The next step is receiving approval by the ATAGI.
The Novavax is the first ever protein-based jab, with Australia ordering 51 million doses.
TGA Professor said a booster requirement and availability for children is set to be discussed.
"The company hasn't yet submitted application to us for that, but we're talking to them," Skerrit said.
"We've given an undertaking as we do for all COVID vaccines. As soon as we got that data we'll review it as an absolute top priority."
Skerritt said many Australians will look to receive the protein-based vaccine, raising the nation's overall target rates.
"I would have had several hundred emails from individuals and groups who have said for whatever reason we would like to have [this] particular vaccine … this just gives them further choice."
Get the latest breaking news from SCA newsrooms around Australia. Short, simple and everything you need to know.
Download LiSTNR and enjoy a new world of audio. All your favourite shows and stations in one library.